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Résumé en
anglais
Ectonucleoside triphosphate diphosphohydrolase-1, the major vascular/immune
ectonucleotidase, exerts anti-thrombotic and immunomodulatory actions by
hydrolyzing extracellular nucleotides (danger signals). Hypertension is characterized
by vascular wall remodeling, endothelial dysfunction, and immune infiltration. Here
our aim was to investigate the impact of arterial hypertension on CD39 expression
and activity in mice. Arterial expression of CD39 was determined by reverse
transcription quantitative real-time PCR in experimental models of hypertension,
including angiotensin II (AngII)-treated mice (1 mg/kg/day, 21 days),
deoxycorticosterone acetate-salt mice (1% salt and uninephrectomy, 21 days), and
spontaneously hypertensive rats. A decrease in CD39 expression occurred in the
resistance and conductance arteries of hypertensive animals with no effect on
lymphoid organs. In AngII-treated mice, a decrease in CD39 protein levels (Western
blot) was corroborated by reduced arterial nucleotidase activity, as evaluated by
fluorescent (etheno)-ADP hydrolysis. Moreover, serum-soluble ADPase activity,
supported by CD39, was significantly decreased in AngII-treated mice. Experiments
were conducted in vitro on vascular cells to determine the elements underlying this
downregulation. We found that CD39 transcription was reduced by proinflammatory
cytokines interleukin (IL)-1β and tumor necrosis factor alpha on vascular smooth
muscle cells and by IL-6 and anti-inflammatory and profibrotic cytokine transforming
growth factor beta 1 on endothelial cells. In addition, CD39 expression was
downregulated by mechanical stretch on vascular cells. Arterial expression and
activity of CD39 were decreased in hypertension as a result of both a proinflammatory
environment and mechanical strain exerted on vascular cells. Reduced
ectonucleotidase activity may alter the vascular condition, thus enhancing arterial
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